Editorial: Covid-19 and obesity
- PMID: 36619552
- PMCID: PMC9817024
- DOI: 10.3389/fendo.2022.1122274
Editorial: Covid-19 and obesity
Keywords: COVID-19; SARS-CoV-2; adipose tissue; obesity; pandemic (COVID-19); vaccine.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Covid-19 and obesity
References
-
- Thakur B, Dubey P, Benitez J, Torres JP, Reddy S, Shokar N, et al. . A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci Rep (2021) 11(1):8562. doi: 10.1038/s41598-021-88130-w - DOI - PMC - PubMed
-
- Guglielmi V, Colangeli L, Scipione V, Ballacci S, Di Stefano M, Hauser L, et al. . Inflammation, underweight, malignancy and a marked catabolic state as predictors for worse outcomes in COVID-19 patients with moderate-to-severe disease admitted to internal medicine unit. PloS One (2022) 17(5):e0268432. doi: 10.1371/journal.pone.0268432 - DOI - PMC - PubMed
-
- Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O'Rahilly S, Aveyard P, et al. . Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol (2021) 9(6):350–9. doi: 10.1016/S2213-8587(21)00089-9 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous